Swiss National Bank Makes New $973,000 Investment in Grail, Inc. (NASDAQ:GRAL)

Swiss National Bank purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 54,500 shares of the company's stock, valued at approximately $973,000. Swiss National Bank owned approximately 0.16% of Grail at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Douglas Lane & Associates LLC acquired a new stake in Grail during the fourth quarter valued at approximately $3,034,000. A. D. Beadell Investment Counsel Inc. bought a new position in shares of Grail during the 4th quarter worth approximately $430,000. FNY Investment Advisers LLC acquired a new stake in Grail in the 4th quarter valued at $26,000. 180 Wealth Advisors LLC bought a new stake in Grail in the fourth quarter valued at $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new position in Grail during the fourth quarter worth $387,000.

Analysts Set New Price Targets

Separately, Morgan Stanley upped their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Grail Stock Up 4.1 %

Shares of GRAL traded up $1.04 on Wednesday, hitting $26.14. The company's stock had a trading volume of 1,178,864 shares, compared to its average volume of 1,217,930. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99. The company has a 50 day moving average price of $34.39 and a 200 day moving average price of $22.66.

Remove Ads

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. As a group, sell-side analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 1,816 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the transaction, the chief financial officer now owns 335,170 shares in the company, valued at $10,457,304. The trade was a 0.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock worth $360,436 in the last 90 days.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.